Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496669 | PMC |
| http://dx.doi.org/10.1007/s00270-021-02862-w | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Correction to: Drug Loss from Paclitaxel Coated Balloons During Preparation, Insertion and Inflation for Angioplasty: A Laboratory Investigation.
Cardiovasc Intervent Radiol
October 2022
Department of Radiology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.
Paclitaxel in real-life data is not associated with reduced survival but has limited benefit in preventing amputation.
Int Angiol
June 2022
Department of Angiology and Vascular Surgery, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, Portugal.
Background: Recent meta-analysis of randomized-controlled trials reported an increased risk of long-term mortality in patients treated with paclitaxel-coated devices (PCD) for femoropopliteal arteries (FP) lesions. However, real-life data on the subject is contradictory and data from CLTI patients is missing. The authors aim to evaluate the impact of PCD for the treatment of FP lesions on long-term mortality and amputation on a real-life cohort up to 5 years.
View Article and Find Full Text PDFCorrection to: Paclitaxel-Coated Balloon Angioplasty for the Treatment of Infrainguinal Arteries: 24-Month Outcomes in the Full Cohort of BIOLUX P-III Global Registry.
Cardiovasc Intervent Radiol
July 2021
Division of Angiology, Department of Internal Medicine, Medical University Graz, Graz, Austria.
Correction to: A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
Cardiovasc Drugs Ther
December 2022
Department of Cardiology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, 100730, Beijing, People's Republic of China.
Correction to: Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty.
Int J Cardiovasc Imaging
October 2019
Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.
In the original publication of the article Fig. 1 was published incorrectly. The corrected Fig.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!